BS8-32285-23205
4 vaccinations
5 coded responses
30 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 522 / IA
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-23
Dose 1 — Pfizer-BioNTech
-
2021-02-26
Registered in v-safe
-
2021-02-26
Survey response — days 1–6 daily, dose 1MedDRA: Exposure to SARS-CoV-2 — Feeling: GoodFree text: Just informed that on 2/22 I was 6' from someone who today 2/26 tested positive for covid19MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-27
- 2021-03-01
- 2021-03-02
- 2021-03-09
-
2021-03-14
Dose 2 — Pfizer-BioNTech
-
2021-03-15
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessFree text: My normal temp is 98.0. A high mild general lassitudeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-17
- 2021-03-19
- 2021-03-21
- 2021-03-28
- 2021-04-04
- 2021-04-11
- 2021-04-19
- 2021-04-25
- 2021-06-13
- 2021-09-12
-
2021-12-01
Dose 3 — Pfizer-BioNTech
-
2022-03-14
Survey response — 12 months, dose 2MedDRA: Asthma, Cough, Influenza, Pain, Productive cough, Pyrexia, Self-medication — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had a flu of some kind with cough that began as an asthma type, impassible to ignore tickle cough. About 12 hours later added aches. Temp up to high of 101.6 with analgesics. Cough morphed to productive. Felt better in a few days. Cough took 2-3 weekMedDRA releases: 2024-11 · check-in free text available
-
2022-04-30
Dose 4 — Pfizer-BioNTech
- 2022-05-04
- 2022-05-05
- 2022-05-06
- 2022-05-07
- 2022-05-14
- 2022-05-21
- 2022-05-28
- 2022-06-04
- 2022-06-11
-
2022-07-30
Survey response — 3 months, dose 4MedDRA: Cough, Dysphonia, Nasopharyngitis, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: A cold- runny nose, hoarseness, cough, temp 99.6-100.4MedDRA releases: 2024-11 · check-in free text available
- 2022-10-29
-
2023-04-30
Survey response — 12 months, dose 4MedDRA: Influenza, Pneumonia, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-04-30
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2023-05-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-23 | Pfizer-BioNTech | |
| 2 | 2021-03-14 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
| 4 | 2022-04-30 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Just informed that on 2/22 I was 6' from someone who today 2/26 tested positive for covid19
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): My normal temp is 98.0. A high mild general lassitude
Release 11 — 12 months, dose 2
Symptoms: Had a flu of some kind with cough that began as an asthma type, impassible to ignore tickle cough. About 12 hours later added aches. Temp up to high of 101.6 with analgesics. Cough morphed to productive. Felt better in a few days. Cough took 2-3 week cut off by CDC
Release 12 — 3 months, dose 4
Symptoms: A cold- runny nose, hoarseness, cough, temp 99.6-100.4
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dysphonia | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Exposure to SARS-CoV-2 | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release